• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-烯醇化酶:新兴的肿瘤相关抗原、癌症生物标志物及肿瘤治疗靶点。

Alpha-Enolase: Emerging Tumor-Associated Antigen, Cancer Biomarker, and Oncotherapeutic Target.

作者信息

Almaguel Frankis A, Sanchez Tino W, Ortiz-Hernandez Greisha L, Casiano Carlos A

机构信息

Center for Health Disparities and Molecular Medicine, Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, United States.

Loma Linda University Cancer Center, Loma Linda, CA, United States.

出版信息

Front Genet. 2021 Jan 28;11:614726. doi: 10.3389/fgene.2020.614726. eCollection 2020.

DOI:10.3389/fgene.2020.614726
PMID:33584813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7876367/
Abstract

Alpha-enolase, also known as enolase-1 (ENO1), is a glycolytic enzyme that "moonlights" as a plasminogen receptor in the cell surface, particularly in tumors, contributing to cancer cell proliferation, migration, invasion, and metastasis. ENO1 also promotes other oncogenic events, including protein-protein interactions that regulate glycolysis, activation of signaling pathways, and resistance to chemotherapy. ENO1 overexpression has been established in a broad range of human cancers and is often associated with poor prognosis. This increased expression is usually accompanied by the generation of anti-ENO1 autoantibodies in some cancer patients, making this protein a tumor associated antigen. These autoantibodies are common in patients with cancer associated retinopathy, where they exert pathogenic effects, and may be triggered by immunodominant peptides within the ENO1 sequence or by posttranslational modifications. ENO1 overexpression in multiple cancer types, localization in the tumor cell surface, and demonstrated targetability make this protein a promising cancer biomarker and therapeutic target. This mini-review summarizes our current knowledge of ENO1 functions in cancer and its growing potential as a cancer biomarker and guide for the development of novel anti-tumor treatments.

摘要

α-烯醇化酶,也称为烯醇化酶-1(ENO1),是一种糖酵解酶,在细胞表面(特别是在肿瘤中)作为纤溶酶原受体发挥“兼职”功能,促进癌细胞的增殖、迁移、侵袭和转移。ENO1还促进其他致癌事件,包括调节糖酵解的蛋白质-蛋白质相互作用、信号通路的激活以及对化疗的抗性。ENO1在多种人类癌症中均有过表达,且常与不良预后相关。在一些癌症患者中,这种表达增加通常伴随着抗ENO1自身抗体的产生,使得该蛋白成为一种肿瘤相关抗原。这些自身抗体在癌症相关性视网膜病变患者中很常见,在其中发挥致病作用,可能由ENO1序列内的免疫显性肽或翻译后修饰触发。ENO1在多种癌症类型中的过表达、在肿瘤细胞表面的定位以及已证实的可靶向性,使得该蛋白成为一种有前景的癌症生物标志物和治疗靶点。这篇小型综述总结了我们目前对ENO1在癌症中的功能及其作为癌症生物标志物的潜力不断增长的认识,以及对新型抗肿瘤治疗开发的指导作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8392/7876367/19ddfa815541/fgene-11-614726-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8392/7876367/19ddfa815541/fgene-11-614726-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8392/7876367/19ddfa815541/fgene-11-614726-g001.jpg

相似文献

1
Alpha-Enolase: Emerging Tumor-Associated Antigen, Cancer Biomarker, and Oncotherapeutic Target.α-烯醇化酶:新兴的肿瘤相关抗原、癌症生物标志物及肿瘤治疗靶点。
Front Genet. 2021 Jan 28;11:614726. doi: 10.3389/fgene.2020.614726. eCollection 2020.
2
ENO1 and Cancer.烯醇化酶1与癌症
Mol Ther Oncolytics. 2022 Jan 3;24:288-298. doi: 10.1016/j.omto.2021.12.026. eCollection 2022 Mar 17.
3
Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT signaling pathway.α-烯醇化酶通过调控 AKT 信号通路促进胃癌细胞的增殖和转移。
Eur J Pharmacol. 2019 Feb 15;845:8-15. doi: 10.1016/j.ejphar.2018.12.035. Epub 2018 Dec 22.
4
Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.α-烯醇化酶通过FAK介导的PI3K/AKT信号通路促进非小细胞肺癌细胞的糖酵解、生长、迁移和侵袭。
J Hematol Oncol. 2015 Mar 8;8:22. doi: 10.1186/s13045-015-0117-5.
5
Alpha-enolase (ENO1), identified as an antigen to monoclonal antibody 12C7, promotes the self-renewal and malignant phenotype of lung cancer stem cells by AMPK/mTOR pathway.α-烯醇化酶(ENO1)被鉴定为单克隆抗体 12C7 的抗原,通过 AMPK/mTOR 通路促进肺癌干细胞的自我更新和恶性表型。
Stem Cell Res Ther. 2021 Feb 12;12(1):119. doi: 10.1186/s13287-021-02160-9.
6
Alpha-Enolase (), a potential target in novel immunotherapies.α-烯醇化酶(),新型免疫疗法的潜在靶标。
Front Biosci (Landmark Ed). 2017 Jan 1;22(5):944-959. doi: 10.2741/4526.
7
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis.α-烯醇化酶(ENO1)控制αv/β3整合素的表达,并调节胰腺癌的黏附、侵袭和转移。
J Hematol Oncol. 2017 Jan 13;10(1):16. doi: 10.1186/s13045-016-0385-8.
8
ENO1 monoclonal antibody inhibits invasion, proliferation and clone formation of cervical cancer cells.ENO1单克隆抗体抑制宫颈癌细胞的侵袭、增殖和克隆形成。
Am J Cancer Res. 2021 May 15;11(5):1946-1961. eCollection 2021.
9
α-enolase is highly expressed in liver cancer and promotes cancer cell invasion and metastasis.α-烯醇化酶在肝癌中高表达,并促进癌细胞侵袭和转移。
Oncol Lett. 2020 Nov;20(5):152. doi: 10.3892/ol.2020.12003. Epub 2020 Aug 24.
10
Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis.烯醇化酶1与多种癌症类型的癌症进展和免疫浸润相关:一项泛癌分析
Front Oncol. 2021 Feb 10;10:593706. doi: 10.3389/fonc.2020.593706. eCollection 2020.

引用本文的文献

1
Machine learning technique-based four-autoantibody test for early detection of esophageal squamous cell carcinoma: a multicenter, retrospective study with a nested case-control study.基于机器学习技术的四种自身抗体检测用于食管癌早期诊断:一项多中心回顾性研究及嵌套病例对照研究
BMC Med. 2025 Apr 23;23(1):235. doi: 10.1186/s12916-025-04066-2.
2
Investigation of new autoantibodies in urothelial bladder cancer for biomarker discovery using immunoproteomics.利用免疫蛋白质组学研究尿路上皮膀胱癌中的新型自身抗体以发现生物标志物。
Discov Oncol. 2025 Mar 31;16(1):436. doi: 10.1007/s12672-025-02167-1.
3
The allergenic potential of enolases: physiological and pathophysiological insights.

本文引用的文献

1
In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination.在胰腺癌中,化疗可增强抗肿瘤反应对肿瘤相关抗原并增强 DNA 疫苗接种的效果。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001071.
2
α-enolase is highly expressed in liver cancer and promotes cancer cell invasion and metastasis.α-烯醇化酶在肝癌中高表达,并促进癌细胞侵袭和转移。
Oncol Lett. 2020 Nov;20(5):152. doi: 10.3892/ol.2020.12003. Epub 2020 Aug 24.
3
Enolase inhibition alters metabolic hormones and inflammatory factors to promote neuroprotection in spinal cord injury.
烯醇化酶的致敏潜力:生理与病理生理学见解
Curr Opin Allergy Clin Immunol. 2025 Jun 1;25(3):212-219. doi: 10.1097/ACI.0000000000001068. Epub 2025 Mar 26.
4
ENO1/Hsp70 Interaction Domains: In Silico and In Vitro Insight for a Putative Therapeutic Target in Cancer.ENO1/Hsp70相互作用结构域:对癌症中一个潜在治疗靶点的计算机模拟和体外研究洞察
ACS Omega. 2025 Jan 30;10(5):5036-5046. doi: 10.1021/acsomega.4c10808. eCollection 2025 Feb 11.
5
Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections.探索疾病中的糖酵解酶:神经退行性疾病、癌症和寄生虫感染中的潜在生物标志物及治疗靶点
Open Biol. 2025 Feb;15(2):240239. doi: 10.1098/rsob.240239. Epub 2025 Feb 5.
6
Targeting enolase 1 reverses bortezomib resistance in multiple myeloma through YWHAZ/Parkin axis.靶向烯醇化酶1通过YWHAZ/帕金轴逆转多发性骨髓瘤中的硼替佐米耐药性。
J Biomed Sci. 2025 Jan 20;32(1):9. doi: 10.1186/s12929-024-01101-x.
7
Multiple Myeloma Cells with Increased Proteasomal and ER Stress Are Hypersensitive to ATX-101, an Experimental Peptide Drug Targeting PCNA.蛋白酶体和内质网应激增加的多发性骨髓瘤细胞对ATX-101(一种靶向增殖细胞核抗原的实验性肽药物)高度敏感。
Cancers (Basel). 2024 Nov 26;16(23):3963. doi: 10.3390/cancers16233963.
8
Osteoblast-Derived ECM1 Promotes Anti-Androgen Resistance in Bone Metastatic Prostate Cancer.成骨细胞衍生的ECM1促进骨转移性前列腺癌的抗雄激素抵抗。
Adv Sci (Weinh). 2025 Jan;12(2):e2407662. doi: 10.1002/advs.202407662. Epub 2024 Nov 20.
9
Targeted Drug Screening Leveraging Senescence-Induced T-Cell Exhaustion Signatures in Hepatocellular Carcinoma.靶向药物筛选利用肝细胞癌衰老诱导的 T 细胞耗竭特征。
Int J Mol Sci. 2024 Oct 18;25(20):11232. doi: 10.3390/ijms252011232.
10
Blood hypercoagulability and thrombosis mechanisms in cancer patients -A brief review.癌症患者的血液高凝性与血栓形成机制——简要综述
Heliyon. 2024 Oct 1;10(19):e38831. doi: 10.1016/j.heliyon.2024.e38831. eCollection 2024 Oct 15.
烯醇化酶抑制作用改变代谢激素和炎症因子,促进脊髓损伤的神经保护。
Neurochem Int. 2020 Oct;139:104788. doi: 10.1016/j.neuint.2020.104788. Epub 2020 Jul 8.
4
Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses.基于瓜氨酸化波形蛋白和烯醇化酶肽的联合疫苗诱导强烈的 CD4 介导的抗肿瘤反应。
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2020-000560.
5
Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cells.烯醇化酶-1表达降低与顺铂耐药卵巢癌细胞内高葡萄糖水平及衰老增加相关。
Am J Transl Res. 2020 Apr 15;12(4):1275-1292. eCollection 2020.
6
Enolase 1 differentially contributes to cell transformation in lung cancer but not in esophageal cancer.烯醇化酶1在肺癌细胞转化中具有不同作用,但在食管癌中并非如此。
Oncol Lett. 2020 Apr;19(4):3189-3196. doi: 10.3892/ol.2020.11427. Epub 2020 Mar 3.
7
ENO1 Acts as a Prognostic Biomarker Candidate and Promotes Tumor Growth and Migration Ability Through the Regulation of Rab1A in Colorectal Cancer.ENO1作为一种预后生物标志物候选物,通过调节Rab1A促进结直肠癌的肿瘤生长和迁移能力。
Cancer Manag Res. 2019 Nov 26;11:9969-9978. doi: 10.2147/CMAR.S226429. eCollection 2019.
8
Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma.α-烯醇化酶(ENO1)作为多发性骨髓瘤新型免疫代谢靶点的临床前验证。
Oncogene. 2020 Mar;39(13):2786-2796. doi: 10.1038/s41388-020-1172-0. Epub 2020 Feb 5.
9
Inhibition of α-enolase affects the biological activity of breast cancer cells by attenuating PI3K/Akt signaling pathway.抑制α-烯醇酶通过减弱 PI3K/Akt 信号通路来影响乳腺癌细胞的生物学活性。
Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):249-257. doi: 10.26355/eurrev_202001_19917.
10
Hyperglycemia promotes Snail-induced epithelial-mesenchymal transition of gastric cancer via activating ENO1 expression.高血糖通过激活ENO1表达促进蜗牛诱导的胃癌上皮-间质转化。
Cancer Cell Int. 2019 Dec 19;19:344. doi: 10.1186/s12935-019-1075-8. eCollection 2019.